The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Coronary Stents Market By 2030 Starting From Its 2026 Size?
The coronary stents market has seen substantial expansion over recent years. It is projected to increase from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. The growth witnessed historically can be linked to the increasing incidence of coronary artery disease, a rising number of percutaneous coronary intervention procedures, advancements in stent coating technologies, the expansion of interventional cardiology services, and improved clinical outcomes associated with coronary stenting.
The coronary stents market size is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $17.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This projected expansion during the forecast period stems from factors such as an aging demographic prone to increased cardiovascular risks, a rising need for less invasive cardiac interventions, the wider embrace of advanced stent technologies, a heightened emphasis on durable vessel healing and improved patient results, and broader availability of cardiac care in developing regions. Key developments expected during this period involve a greater uptake of drug-eluting and dual therapy stents, a stronger inclination towards minimally invasive coronary procedures, an intensified drive to mitigate restenosis and thrombosis hazards, the broader utilization of bioresorbable and biodegradable stents, and an escalating requirement for innovative stent materials and designs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
Which Market Drivers Are Supporting The Expansion Of The Coronary Stents Market?
The growing occurrence of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the coronary stent market going forward. These diseases encompass various heart and blood vessel conditions, such as coronary artery disease, heart failure, stroke, and high blood pressure. The increase in CVDs is linked to an aging global population and a higher incidence of risk factors including obesity, diabetes, inactive routines, unhealthy eating habits, and stress. Coronary stents become necessary in such cases to unblock or widen constricted coronary arteries, thereby enhancing blood circulation to the heart and lowering the likelihood of heart attacks. For example, data from October 2024, provided by the US government agency, the Centers for Disease Control and Prevention, revealed that in 2023, cardiovascular disease was responsible for 919,032 fatalities, representing approximately one in every three deaths. Consequently, the escalating incidence of cardiovascular diseases (CVDs) is significantly contributing to the growth of the coronary stent market.
Which Segment Categories Define The Coronary Stents Market?
The coronary stents market covered in this report is segmented –
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents
What Major Market Trends Are Driving Changes In The Coronary Stents Market?
Leading companies in the coronary stent market are introducing advanced products, such as drug-eluting stents, aimed at decreasing the necessity for recurrent interventions when contrasted with bare-metal stents. These drug-eluting stents are specialized devices for coronary arteries, featuring a medicinal coating that steadily releases drugs to prevent the arteries from narrowing again. For instance, in May 2024, Abbott, a US-based healthcare company, rolled out the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its improved design, a novel delivery system, and distinct size options, specifically engineered to manage complex cases. It maintains the specialized coating that diminishes the risk of artery re-blockage, consistent with other XIENCE stents. This particular stent boasts an outstanding safety profile, substantiated by more than 120 clinical trials involving over 120,000 patients.
Who Are The Top Companies Competing In The Coronary Stents Market?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys
Read the full coronary stents market report here:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
How Is The Coronary Stents Market Distributed Across Key Geographic Regions?
North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Coronary Stents Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp
Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company
Atherectomy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report
Coronary Angiography Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model